Literature DB >> 16534198

The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis.

Libor Vítek1, Ladislav Novotný, Michal Sperl, Robert Holaj, Jirí Spácil.   

Abstract

BACKGROUND: Serum bilirubin is negatively associated with the development of coronary heart disease. In the present study, we have focused on the analysis of intima-media thickness (IMT) of the common carotid artery in hyper- and normobilirubinemic subjects.
METHODS: The study was performed on 111 men without manifested atherosclerosis. In all subjects, complete biochemical tests were determined along with the examination of IMT by carotid ultrasound.
RESULTS: The mean IMT in hyperbilirubinemic subjects as compared with controls was substantially lower (p=0.017), and hyperbilirubinemic men also had very low age-adjusted prevalence odds ratios for having IMT above the 50th percentiles of controls, even after adjustment for selected vascular risk factors (p=0.034).
CONCLUSIONS: In the present study, we demonstrate the inverse relationship between serum bilirubin and IMT in healthy men. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16534198     DOI: 10.1159/000091966

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  22 in total

1.  Hyperbilirubinemia and intermittent lower urinary tract dysfunction.

Authors:  Vesna Stojanović; Tamara Vukavić
Journal:  Indian J Pediatr       Date:  2011-01-04       Impact factor: 1.967

2.  Hyperbilirubinemia and intermittent lower urinary tract dysfunction: a story.

Authors:  Viroj Wiwanitkit
Journal:  Indian J Pediatr       Date:  2011-03-05       Impact factor: 1.967

3.  Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?

Authors:  Pernette R W de Sauvage Nolting; D Meeike Kusters; Barbara A Hutten; John J P Kastelein
Journal:  J Lipid Res       Date:  2011-06-23       Impact factor: 5.922

4.  Association of Serum Bilirubin with SYNTAX Score and Future Cardiovascular Events in Patients Undergoing Coronary Intervention.

Authors:  Chun-Chin Chang; Chien-Yi Hsu; Po-Hsun Huang; Chia-Hung Chiang; Shao-Sung Huang; Hsin-Bang Leu; Chin-Chou Huang; Jaw-Wen Chen; Shing-Jong Lin
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

5.  Association of serum total bilirubin levels with the severity, extent and subtypes of coronary atherosclerotic plaques detected by coronary CT angiography.

Authors:  Uğur Canpolat; Kudret Aytemir; Hikmet Yorgun; Tuncay Hazırolan; Ergün Barış Kaya; Levent Şahiner; Hamza Sunman; Lale Tokgözoğlu; Giray Kabakcı; Ali Oto
Journal:  Int J Cardiovasc Imaging       Date:  2013-04-02       Impact factor: 2.357

6.  Traditional laboratory measures of cardiovascular risk in hereditary spherocytosis.

Authors:  Shelley E Crary; Sarah Troendle; Naveed Ahmad; George R Buchanan
Journal:  Pediatr Blood Cancer       Date:  2010-10       Impact factor: 3.167

7.  Bilirubin protects grafts against nonspecific inflammation-induced injury in syngeneic intraportal islet transplantation.

Authors:  Huaqiang Zhu; Jizhou Wang; Hongchi Jiang; Yong Ma; Shangha Pan; Shiva Reddy; Xueying Sun
Journal:  Exp Mol Med       Date:  2010-11-30       Impact factor: 8.718

8.  Bilirubin levels in patients with systemic lupus erythematosus: increased or decreased?

Authors:  Zaixing Yang; Yan Liang; Chang Li; Weiqiang Xi; Renqian Zhong
Journal:  Rheumatol Int       Date:  2011-06-21       Impact factor: 2.631

9.  Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  K H Chan; R L O'Connell; D R Sullivan; L S Hoffmann; K Rajamani; M Whiting; M W Donoghoe; M Vanhala; A Hamer; B Yu; R Stocker; M K C Ng; A C Keech
Journal:  Diabetologia       Date:  2013-01-17       Impact factor: 10.122

10.  Low-normal free thyroxine confers decreased serum bilirubin in type 2 diabetes mellitus.

Authors:  Petronella E Deetman; Arjan J Kwakernaak; Stephan J L Bakker; Robin P F Dullaart
Journal:  Thyroid       Date:  2013-09-04       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.